Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 15, 2023
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
[ Wed, Feb 15th 2023
] - WOPRAI
Andrew Fein Maintained (UBX) at Strong Buy and Held Target at $10 on, Feb 15th, 2023
Andrew Fein of HC Wainwright & Co., Maintained "Unity Biotechnology, Inc." (UBX) at Strong Buy and Held Target at $10 on, Feb 15th, 2023.
Andrew has made no other calls on UBX in the last 4 months.
There are 2 other peers that have a rating on UBX. Out of the 2 peers that are also analyzing UBX, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $12 on, Wednesday, November 16th, 2022
- Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $36 on, Wednesday, November 2nd, 2022
